Loading…
This event has ended. Visit the official site or create your own event on Sched.

View analytic
Tuesday, June 28 • 10:30am - 11:30am
#215: Exploring the Use of Virtual Technologies and Virtual Teams Within Medical Affairs Organizations

Sign up or log in to save this to your schedule and see who's attending!

Limited Capacity seats available

Component Type: Session
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-16-603-L04-P; CME 1.00; IACET 1.00; RN 1.00

Medical affairs teams are involved in a wealth of communication methods across the pharmaceutical/device, and biotechnology industries. Communication is at the core of each job unit. However, with the evolving reliance on technology, typical communication methods are being disrupted. One of the greatest issues facing medical affairs teams in recent years has been how to assess and incorporate these new technologies, especially virtual technologies, and expand the impact of their organization. With iPads, notebooks, wearable devices, and other advances in the electronic space, medical affairs team members, both internal facing and external facing, need to become proficient with these new technologies. Additionally, organizations need to establish rules regarding the use of the technologies. This session will address some of the issues and benefits of implementing these new, disruptive technologies within both established and emerging medical affairs teams.

Learning Objectives

Discuss the issues and benefits of implementing new, disruptive technologies for use with medical affairs teams.

Chair

J. Lynn Bass

Speaker

Experience of Leveraging External Virtual Teams to Expand the Capabilities of a Newly Formed Medical Affairs Organization
Rachel Couchenour

Meeting Thought Leader Needs with Technology
Craig J. Klinger, RPh



Chair
avatar for J. Lynn Bass

J. Lynn Bass

Director, Medical Affairs, Jazz Pharmaceuticals
Lynn has 16+ years of experience in the Medical Science Liaison (MSL) profession with tenures at Baxter BioScience, Lilly, Amgen, and most recently Jazz Pharmaceuticals. She has been an active member of the MSL community for over 14 years and has co-authored numerous MSL surveys. Currently, Lynn serves as the Chair, DIA Medical Science Liaison Community.

Speakers
avatar for Rachel Couchenour

Rachel Couchenour

Senior Director, Medical Affairs, Mateon Therapeutics
Rachel Couchenour, PharmD, MBA is a recognized leader with 15 years experience in the pharmaceutical industry. She currently serves as Sr. Director, Medical Affairs at Mateon Therapeutics, accountable for building and executing the medical affairs strategy for this clinical stage oncology biopharmaceutical company. Prior to joining the industry she was in academia with clinical practice in ambulatory care. BS in Pharmacy, UNC-Chapel Hill... Read More →
avatar for Craig Klinger

Craig Klinger

Consultant, Field Medical Liaison Strategy and Capabilities - Trainer, Lilly USA, LLC
Craig has been an employee of Eli Lilly and Company for the past 25 years. Craig was a Senior Medical Liaison Consultant in the New York City Metropolitan area for over 13 years. He currently is the USMD Operations Consultant - Trainer for all on boarding MLs at Lilly.


Tuesday June 28, 2016 10:30am - 11:30am
202AB Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA